Biotech Values

[maverick_1]

re IMUC "Penny Stock Arena": Setup for $Raise PH3 GMB (late 2015)

Only 6 days old is this from IMUC 10Q:

As of June 30, 2015, we had working capital of $31,388,966, compared to working capital of $23,152,970 as of December 31, 2014.The estimated cost of completing the development of any of our current immunotherapy product candidates and of obtaining all required regulatory approvals to market either of those product candidates is substantially greater than the amount of funds we currently have available. However, we believe that our existing cash balances will be sufficient to fund our operations for at least the next twelve months from the date of filing this Quarterly report on Form 10-Q, although there is no assurance that such proceeds will be sufficient.

Source:http://secfilings.nasdaq.com/filingFrameset.asp?FileName=0001564590-15-006689%2Etxt&FilePath=%5C2015%5C08%5C07%5C&CoName=IMMUNOCELLULAR+THERAPEUTICS%2C+LTD%2E&FormType=10-Q&RcvdDate=8%2F7%2F2015&pdf=

Looks like a capital raise NEEDED to begin their PH3 GBM in late 2015
From their PR today:

Patient enrollment is anticipated to begin in the late third quarter or early fourth quarter of 2015.

Note: do NOT follow IMUC but just did a quickie. Hence have not vetted 10Q.